Mitogen-activated protein kinases and the evolution of Alzheimer's: A revolutionary neurogenetic axis for therapeutic intervention?

Progress in Neurobiology

Volumn 73, Issue 5, 2004, Pages 359-377

  Haddad, John J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Fac Med Sir Alexander Fleming B   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; AMYLOID BETA PROTEIN; BINDING PROTEIN; CALMODULIN; CALYCULIN A; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN DEPENDENT KINASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MYELIN BASIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; PROTEIN DERIVATIVE; PROTEIN PRECURSOR; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; TAU PROTEIN; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR;

ALLELE; ALZHEIMER DISEASE; CORRELATION ANALYSIS; CROSS COUPLING REACTION; CYTOKINE PRODUCTION; DEMENTIA; DIAGNOSTIC VALUE; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NERVE CELL NETWORK; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROTRANSMISSION; OXIDATION KINETICS; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS; TECHNIQUE;

ALZHEIMER DISEASE; ANIMALS; ENZYME INHIBITORS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 4243146359     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2004.06.002     Document Type: Review

References (204)

1. K. Abe, and H. Saito Amyloid β neuro-toxicity not mediated by the mitogen-activated protein kinase cascade in cultured rat hippocampal and cortical neurons Neurosci. Lett. 292 2000 1 4
2. B.H. Anderton, J. Betts, W.P. Blackstock, J.P. Brion, S. Chapman, J. Connell, R. Dayanandan, J.M. Gallo, G. Gibb, D.P. Hanger, M. Hutton, E. Kardalinou, K. Leroy, S. Lovestone, T. Mack, C.H. Reynolds, and M. Van Slegtenhorst Sites of phosphorylation in Tau and factors affecting their regulation Biochem. Soc. Symp. 67 2001 73 80
3. E. Angulo, V. Casado, J. Mallol, E.I. Canela, F. Vinals, I. Ferrer, C. Lluis, and R. Franco A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation Brain Pathol. 13 2003 440 451
4. A.E. Aplin, G.M. Gibb, J.S. Jacobsen, J.M. Gallo, and B.H. Anderton In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3β J. Neurochem. 67 1996 699 707
5. C. Atzori, B. Ghetti, R. Piva, A.N. Srinivasan, P. Zolo, M.B. Delisle, S.S. Mirra, and A. Migheli Activation of the JNK/p38 pathway occurs in diseases characterized by Tau protein pathology and is related to Tau phosphorylation but not to apoptosis J. Neuropathol. Exp. Neurol. 60 2001 1190 1197
6. J. Avruch, A. Khokhlatchev, J.M. Kyriakis, Z. Luo, G. Tzivion, D. Vavvas, and X.F. Zhang Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade Rec. Prog. Horm. Res. 56 2001 127 155
7. R.K. Barr, and M.A. Bogoyevitch The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs) Int. J. Biochem. Cell Biol. 33 2001 1047 1063
8. L. Baum, R. Seger, J.R. Woodgett, S. Kawabata, K. Maruyama, M. Koyama, J. Silver, and T. Saitoh Over-expressed Tau protein in cultured cells is phosphorylated without formation of PHF: Implication of phospho-protein phosphatase involvement Brain Res. Mol. Brain Res. 34 1995 1 17
9. T. Beardsley Unraveling Alzheimer's: a major cause of the disease yields to researchers Sci. Am. 269 1993 28 31
10. T. Beardsley Putting Alzheimer's to the tests: several new techniques may detect the disease Sci. Am. 272 1995 12 13
11. M.M. Belcheva, and C.J. Coscia Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase Neurosignals 11 2002 34 44
12. P. Bendinelli, R. Piccoletti, P. Maroni, and A. Bernelli-Zazzera The liver response to in vivo heat shock involves the activation of MAP kinases and RAF and the tyrosine phosphorylation of Shc proteins Biochem. Biophys. Res. Commun. 216 1995 54 61
13. R. Bi, G. Broutman, M.R. Foy, R.F. Thompson, and M. Baudry The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus Proc. Natl. Acad. Sci. U.S.A. 97 2000 3602 3607
14. ERK beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease Biochem. Biophys. Res. Commun. 200 1994 187 194
15. D.V. Bulavin, S.A. Amundson, and A.J. Fornace p38 and Chk1 kinases: different conductors for the G(2)/M checkpoint symphony Curr. Opin. Genet. Dev. 12 2002 92 97
16. L. Burnham Alzheimer's proteins Sci. Am. 258 1988 23 24
17. E. Cano, and L.C. Mahadevan Parallel signal processing among mammalian MAPKs Trends Biochem. Sci. 20 1995 117 122
18. S.M. Cazaubon, F. Ramos-Morales, S. Fischer, F. Schweighoffer, A.D. Strosberg, and P.O. Couraud Endothelin induces tyrosine phosphorylation and GRB2 association of Shc in astrocytes J. Biol. Chem. 269 1994 24805 24809
19. P. Chakraborty G-protein-mediated signaling and its control in macrophages and mammalian cells Crit. Rev. Microbiol. 27 2001 1 8
20. 2+): emerging roles in regulating diverse physiological functions Cell. Signal. 12 2000 361 366
21. Y. Chen, D. Grall, A.E. Salcini, P.G. Pelicci, J. Pouyssegur, and E. Van Obberghen-Schilling Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor EMBO J. 15 1996 1037 1044
22. G.J. Chen, J. Xu, S.A. Lahousse, N.L. Caggiano, and S.M. de la Monte Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection J. Alzheimers Dis. 5 2003 209 228
23. Y.H. Chong, J.H. Sung, S.A. Shin, J.H. Chung, and Y.H. Suh Effects of the β-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-α and matrix metalloproteinase-9 by human monocytic THP-1 J. Biol. Chem. 276 2001 23511 23517
24. M.H. Cobb, S. Xu, J.E. Hepler, M. Hutchison, J. Frost, and D.J. Robbins Regulation of the MAP kinase cascade Cell. Mol. Biol. Res. 40 1994 253 256
25. S.A. Courtneidge, S. Fumagalli, M. Koegl, G. Superti-Furga, and G.M. Twamley-Stein The Src family of protein tyrosine kinases: regulation and functions Dev. Suppl. 1 1993 57 64
26. A. Cuenda Mitogen-activated protein kinase kinase 4 (MKK4) Int. J. Biochem. Cell Biol. 32 2000 581 587
27. P.J. Cullen, and P.J. Lockyer Integration of calcium and Ras signalling Nat. Rev. Mol. Cell Biol. 3 2002 339 348
28. S.A. Dalrymple p38 mitogen activated protein kinase as a therapeutic target for Alzheimer's disease J. Mol. Neurosci. 19 2002 295 299
29. W.M. Daniels, J. Hendricks, R. Salie, and J.J. Taljaard The role of the MAP-kinase superfamily in beta-amyloid toxicity Metab. Brain Dis. 16 2001 175 185
30. 2+ and protein kinase C-dependent mechanisms involved in gastrin-induced Shc/Grb2 complex formation and P44-mitogen-activated protein kinase activation Biochem. J. 325 1997 383 389
31. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239 252
32. S.M. de la Monte, N. Ganju, N. Feroz, T. Luong, K. Banerjee, J. Cannon, and J.R. Wands Oxygen free radical injury is sufficient to cause some Alzheimer-type molecular abnormalities in human CNS neuronal cells J. Alzheimers Dis. 2 2000 261 281
33. K. Del Villar, and C.A. Miller Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons Proc. Natl. Acad. Sci. U.S.A. 101 2004 4210 4215
34. D.T. Denhardt Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: The potential for multiplex signalling Biochem. J. 318 1996 729 747
35. N. Dhanasekaran, and J.M. Dermott Signaling by the G12 class of G proteins Cell Signal 8 1996 235 245
36. M. Dickens, J.S. Rogers, J. Cavanagh, A. Raitano, Z. Xia, J.R. Halpern, M.E. Greenberg, C.L. Sawyers, and R.J. Davis A cytoplasmic inhibitor of the JNK signal transduction pathway Science 277 1997 693 696
37. K.T. Dineley, M. Westerman, D. Bui, K. Bell, K.H. Ashe, and J.D. Sweatt Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease J. Neurosci. 21 2001 4125 4133
38. C. Dong, R.J. Davis, and R.A. Flavell Signaling by the JNK group of MAP kinases: c-Jun N-terminal kinase J. Clin. Immunol. 21 2001 253 257
39. F.J. Ekinci, and T.B. Shea Hyper-activation of mitogen-activated protein kinase increases phospho-Tau immunoreactivity within human neuroblastoma: Additive and synergistic influence of alteration of additional kinase activities Cell. Mol. Neurobiol. 19 1999 249 260
40. F.J. Ekinci, K.U. Malik, and T.B. Shea Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to β-amyloid. MAP kinase mediates β-amyloid-induced neuro-degeneration J. Biol. Chem. 274 1999 30322 30327
41. J.M. English, and M.H. Cobb Pharmacological inhibitors of MAPK pathways Trends Pharmacol. Sci. 23 2002 40 45
42. J. English, G. Pearson, J. Wilsbacher, J. Swantek, M. Karandikar, S. Xu, and M.H. Cobb New insights into the control of MAP kinase pathways Exp. Cell Res. 253 1999 255 270
43. H. Enslen, J. Raingeaud, and R.J. Davis Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6 J. Biol. Chem. 273 1998 1741 1748
44. D. Erickson Model mice: transgenic animals and Alzheimer's research Sci. Am. 265 1991 34
45. A.K. Erickson, D.M. Payne, P.A. Martino, A.J. Rossomando, J. Shabanowitz, M.J. Weber, D.F. Hunt, and T.W. Sturgill Identification by mass spectrometry of threonine 97 in bovine myelin basic protein as a specific phosphorylation site for mitogen-activated protein kinase J. Biol. Chem. 265 1990 19728 19735
46. B. Errede, R.M. Cade, B.M. Yashar, Y. Kamada, D.E. Levin, K. Irie, and K. Matsumoto Dynamics and organization of MAP kinase signal pathways Mol. Reprod. Dev. 42 1995 477 485
47. I. Ferrer, R. Blanco, M. Carmona, and B. Puig Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in Tau deposits in neurons and glial cells in tauopathies J. Neural. Transm. 108 2001 1397 1415
48. Y. Fleming, C.G. Armstrong, N. Morrice, A. Paterson, M. Goedert, and P. Cohen Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7 Biochem. J. 352 2000 145 154
49. R.A. Floyd Antioxidants, oxidative stress, and degenerative neurological disorders Proc. Soc. Exp. Biol. Med. 222 1999 236 245
50. R.A. Frye Involvement of G proteins, cytoplasmic calcium, phospholipases, phospholipid-derived second messengers, and protein kinases in signal transduction from mitogenic cell surface receptors Cancer Treat. Res. 63 1992 281 299
51. G. Gadea, L. Lapasset, C. Gauthier-Rouviere, and P. Roux Regulation of Cdc42-mediated morphological effects: a novel function for p53 EMBO J. 21 2002 2373 2382
52. P. Ganju, J.P. O'Bryan, C. Der, J. Winter, and I.F. James Differential regulation of SHC proteins by nerve growth factor in sensory neurons and PC12 cells Eur. J. Neurosci. 10 1998 1995 2008
53. T.D. Garver, G.A. Oyler, K.A. Harris, R. Polavarapu, Z. Damuni, R.A. Lehman, and M.L. Billingsley Tau phosphorylation in brain slices: pharmacological evidence for convergent effects of protein phosphatases on Tau and mitogen-activated protein kinase Mol. Pharmacol. 47 1995 745 756
54. O. Ghribi, P. Prammonjago, M.M. Herman, N.K. Spaulding, and J. Savory Abeta(1-42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau Brain Res. Mol. Brain Res. 119 2003 201 206
55. S.M. Grant, A. Morinville, D. Maysinger, M. Szyf, and A.C. Cuello Phosphorylation of mitogen-activated protein kinase is altered in neuro-ectodermal cells over-expressing the human amyloid precursor protein 751 isoform Brain Res. Mol. Brain Res. 72 1999 115 120
56. S.M. Greenberg, E.H. Koo, D.J. Selkoe, W.Q. Qiu, and K.S. Kosik Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances Tau phosphorylation Proc. Natl. Acad. Sci. U.S.A. 91 1994 7104 7108
57. K.L. Guan The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus Cell Signal 6 1994 581 589
58. M. Guha, and N. Mackman LPS induction of gene expression in human monocytes Cell Signal 13 2001 85 94
59. S. Guise, D. Braguer, G. Carles, A. Delacourte, and C. Briand Hyper-phosphorylation of Tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells J. Neurosci. Res. 63 2001 257 267
60. J.J. Haddad VX-745: vertex pharmaceuticals Curr. Opin. Investig. Drugs 2 2001 1070 1076
61. p38-dependent regulation of pro-inflammatory cytokine production Biochem. Pharmacol. 63 2002 305 320
62. J.J. Haddad Oxygen homeostasis, thiol equilibrium and redox regulation of signaling transcription factors in the alveolar epithelium Cell Signal 14 2002 799 810
63. J.J. Haddad Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors Cell Signal 14 2002 879 897
64. J.J. Haddad Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics Free Radic. Biol. Med. 33 2002 907 926
65. J.J. Haddad Cytokines and related receptor-mediated signaling pathways Biochem. Biophys. Res. Commun. 297 2002 700 713
66. J.J. Haddad Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury I. Role for nuclear factor-κB Crit. Care 6 2002 481 490
67. J.J. Haddad Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury II. Role for hypoxia-inducible factor-1α Crit. Care 7 2003 47 54
68. J.J. Haddad Redox and oxidant-mediated regulation of apoptosis signaling pathways: immuno-pharmaco-redox conception of oxidative siege versus cell death commitment Int. Immunopharmacol. 4 2004 475 493
69. J.J. Haddad Oxygen sensing and oxidant/redox-related pathways Biochem. Biophys. Res. Commun. 316 2004 969 977
70. 2-evoked regulation of HIF-1α and NF-κB in perinatal lung epithelium requires glutathione biosynthesis Am. J. Physiol. Lung Cell. Mol. Physiol. 278 2000 L492 L503
71. J.J. Haddad, and S.C. Land The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-κB (RelA)-selective targeting Biochem. Biophys. Res. Commun. 271 2000 257 267
72. J.J. Haddad, and S.C. Land Redox/ROS regulation of lipopolysaccharide- induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-α biosynthesis Br. J. Pharmacol. 135 2002 520 536
73. J.J. Haddad, and C.S. Fahlman Redox and oxidant-mediated regulation of interleukin-10: an anti-inflammatory, antioxidant cytokine? Biochem. Biophys. Res. Commun. 297 2002 163 176
74. J.J. Haddad, R.E. Olver, and S.C. Land Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity: evidence for inhibition by glutathione oxidation in alveolar epithelial cells J. Biol. Chem. 275 2000 21130 21139
75. J.J. Haddad, N.E. Saadé, and B. Safieh-Garabedian Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary- adrenal revolving axis J. Neuroimmunol. 133 2002 1 19
76. J.J. Haddad, N.E. Saadé, and B. Safieh-Garabedian Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signaling modules targets for the anti-inflammatory action of this cytokine? Cell Signal 15 2003 255 267
77. C. Hagemann, and J.L. Blank The ups and downs of MEK kinase interactions Cell Signal 13 2001 863 875
78. M. Haneda, T. Sugimoto, and R. Kikkawa Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade Eur. J. Pharmacol. 365 1999 1 7
79. S.J. Harper, and P. LoGrasso Signalling for survival and death in neurones: the role of stress-activated kinases JNK and p38 Cell Signal 13 2001 299 310
80. C.A. Hazzalin, and L.C. Mahadevan MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3 2002 30 40
81. E. Herlaar, and Z. Brown p38 MAPK signaling cascades in inflammatory disease Mol. Med. Today 5 1999 439 447
82. A. Hindley, and W. Kolch Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases J. Cell Sci. 115 2002 1575 1581
83. D.T. Ho, H. Shayan, and T.H. Murphy Okadaic acid induces hyper-phosphorylation of Tau independently of mitogen-activated protein kinase activation J. Neurochem. 68 1997 106 111
84. M. Holmes-McNary Nuclear factor-κB signaling in catabolic disorders Curr. Opin. Clin. Nutr. Metab. Care 5 2002 255 263
85. A.K. Howe, A.E. Aplin, and R.L. Juliano Anchorage-dependent ERK signaling: mechanisms and consequences Curr. Opin. Genet. Dev. 12 2002 30 35
86. J.J. Hoozemans, R. Veerhuis, A.J. Rozemuller, T. Arendt, and P. Eikelenboom Neuronal COX-2 expression and phosphorylation of pRb precede p38 MAPK activation and neurofibrillary changes in AD temporal cortex Neurobiol. Dis. 15 2004 492 499
87. D.Y. Hwang, J.S. Cho, S.H. Lee, K.R. Chae, H.J. Lim, S.H. Min, S.J. Seo, Y.S. Song, C.W. Song, S.G. Paik, Y.Y. Sheen, and Y.K. Kim Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw Exp. Neurol. 186 2004 20 32
88. B.T. Hyman, T.E. Elvhage, and J. Reiter Extracellular signal regulated kinases Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease Am. J. Pathol. 144 1994 565 572
89. H. Ichijo From receptors to stress-activated MAP kinases Oncogene 18 1999 6087 6093
90. T. Inui, N. Shinomiya, M. Fukasawa, N. Kuranaga, S. Ohkura, and S. Seki Telomerase activation and MAPK pathways in regenerating hepatocytes Hum. Cell 14 2001 275 282
91. Y.T. Ip, and R.J. Davis Signal transduction by the c-Jun N-terminal kinase (JNK): from inflammation to development Curr. Opin. Cell Biol. 10 1998 205 219
92. N.D. James, D.R. Davis, J. Sindon, D.P. Hanger, J.P. Brion, C.C. Miller, M.P. Rosenberg, B.H. Anderton, and F. Propst Neurodegenerative changes including altered Tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase Mos Neurobiol. Aging 17 1996 235 241
93. S.M. Jenkins, M. Zinnerman, C. Garner, and G.V. Johnson Modulation of Tau phosphorylation and intracellular localization by cellular stress Biochem. J. 345 2000 263 270
94. M.K. Jones, H. Wang, B.M. Peskar, E. Levin, R.M. Itani, I.J. Sarfeh, and A.S. Tarnawski Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing Nat. Med. 5 1999 1418 1423
95. G.V. Johnson, and C.D. Bailey The p38 MAP kinase signaling pathway in Alzheimer's disease Exp. Neurol. 183 2003 263 268
96. S.A. Kanaan, B. Safieh-Garabedian, J.J. Haddad, S.F. Atweh, A.M. Abdelnoor, S.J. Jabbur, and N.E. Saadé Effects of various analgesic and anti-inflammatory drugs on endotoxin-induced hyperalgesia in rats and mice Pharmacology 54 1997 285 297
97. J.S. Kennedy, M. Raab, and C.E. Rudd Signaling scaffolds in immune cells Cell Calcium 26 1999 227 235
98. I.J. Kim, K.W. Lee, B.Y. Park, J.K. Lee, J. Park, I.Y. Choi, S.J. Eom, T.S. Chang, M.J. Kim, Y.I. Yeom, S.K. Chang, Y.D. Lee, E.J. Choi, and P.L. Han Molecular cloning of multiple splicing variants of JIP-1 preferentially expressed in brain J. Neurochem. 72 1999 1335 1343
99. R.B. Knowles, J. Chin, C.T. Ruff, and B.T. Hyman Demonstration by fluorescence resonance energy transfer of a close association between activated MAP kinase and neurofibrillary tangles: implications for MAP kinase activation in Alzheimer disease J. Neuropathol. Exp. Neurol. 58 1999 1090 1098
100. M. Koistinaho, M.I. Kettunen, G. Goldsteins, R. Keinanen, A. Salminen, M. Ort, J. Bures, D. Liu, R.A. Kauppinen, L.S. Higgins, and J. Koistinaho Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation Proc. Natl. Acad. Sci. U.S.A. 99 2002 1610 1615
101. W. Kolch Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions Biochem. J. 351 2000 289 305
102. A.Y. Korneyev Stress-induced Tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity Neurochem. Res. 23 1998 1539 1543
103. S. Kumar, P.C. McDonnell, R.J. Gum, A.T. Hand, J.C. Lee, and P.R. Young Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles Biochem. Biophys. Res. Commun. 235 1997 533 538
104. J.C. Lee, and P.R. Young Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms J. Leukoc. Biol. 59 1996 152 157
105. J.C. Lee, S. Kumar, D.E. Griswold, D.C. Underwood, B.J. Votta, and J.L. Adams Inhibition of p38 MAP kinase as a therapeutic strategy Immunopharmacology 47 2000 185 201
106. J.T. Lee Jr., and J.A. McCubrey The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia Leukemia 16 2002 486 507
107. S. Leppa, and D. Bohmann Diverse functions of JNK signaling and c-Jun in stress response and apoptosis Oncogene 18 1999 6158 6162
108. E.R. Levin Cellular functions of plasma membrane estrogen receptors Steroids 67 2002 471 475
109. T.S. Lewis, P.S. Shapiro, and N.G. Ahn Signal transduction through MAP kinase cascades Adv. Cancer Res. 74 1998 49 139
110. Y. Li, L. Liu, S.W. Barger, R.E. Mrak, and W.S. Griffin Vitamin E suppression of microglial activation is neuroprotective J. Neurosci. Res. 66 2001 163 170
111. C. Liebmann Regulation of MAP kinase activity by peptide receptor signaling pathway: paradigms of multiplicity Cell Signal 13 2001 777 785
112. M. Lopez-Ilasaca Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades Biochem. Pharmacol. 56 1998 269 277
113. S. Lovestone, C.H. Reynolds, D. Latimer, D.R. Davis, B.H. Anderton, J.M. Gallo, D. Hanger, S. Mulot, B. Marquardt, S. Stabel, J.R. Woodgett, and C.C.K. Miller Alzheimer's disease-like phosphorylation of the microtubule-associated protein Tau by glycogen synthase kinase-3 in transfected mammalian cells Curr. Biol. 4 1994 1077 1086
114. V.L. Lowes, N.Y. Ip, and Y.H. Wong Integration of signals from receptor tyrosine kinases and γ protein-coupled receptors Neurosignals 11 2002 5 19
115. E.M. Mandelkow, J. Biernat, G. Drewes, B. Steiner, B. Lichtenberg-Kraag, H. Wille, N. Gustke, and E. Mandelkow Microtubule-associated protein Tau, paired helical filaments, and phosphorylation Ann. N.Y. Acad. Sci. 695 1993 209 216
116. E.M. Mandelkow, J. Biernat, G. Drewes, N. Gustke, B. Trinczek, and E. Mandelkow Tau domains, phosphorylation and interactions with microtubules Neurobiol. Aging 16 1995 355 362
117. C.J. Marshall MAP kinase kinase kinase, MAP kinase kinase and MAP kinase Curr. Opin. Genet. Dev. 4 1994 82 89
118. M.S. Marshall Ras target proteins in eukaryotic cells FASEB J. 9 1995 1311 1318
119. D. Martindale Peeling plaque Sci. Am. 286 2002 20
120. J. Marx Neuroscience: new leads on the 'how' of Alzheimer's Science 293 2001 2192 2194
121. S. Matsuda, T. Yasukawa, Y. Homma, Y. Ito, T. Niikura, T. Hiraki, S. Hirai, S. Ohno, Y. Kita, M. Kawasumi, K. Kouyama, T. Yamamoto, J.M. Kyriakis, and I. Nishimoto c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet- brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK J. Neurosci. 21 2001 6597 6607
122. J.A. McCubrey, W.S. May, V. Duronio, and A. Mufson Serine/threonine phosphorylation in cytokine signal transduction Leukemia 14 2000 9 21
123. D.R. McDonald, M.E. Bamberger, C.K. Combs, and G.E. Landreth β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP-1 monocytes J. Neurosci. 18 1998 4451 4460
124. A.B. Meriin, V.L. Gabai, J. Yaglom, V.I. Shifrin, and M.Y. Sherman Proteasome inhibitors activate stress kinases and induce Hsp72: diverse effects on apoptosis J. Biol. Chem. 273 1998 6373 6379
125. K. Mielke, and T. Herdegen JNK and p38 stress kinases: degenerative effectors of signal-transduction-cascades in the nervous system Prog. Neurobiol. 61 2000 45 60
126. J. Mills, and P.B. Reiner Mitogen-activated protein kinase is involved in N-methyl-D-aspartate receptor regulation of amyloid precursor protein cleavage Neuroscience 94 1999 1333 1338
127. G. Mordret MAP kinase kinase: a node connecting multiple pathways Biol. Cell 79 1993 193 207
128. D.K. Morrison Mechanisms regulating Raf-1 activity in signal transduction pathways Mol. Reprod. Dev. 42 1995 507 514
129. Y. Murayama, S. Takeda, K. Yonezawa, U. Giambarella, I. Nishimoto, and E. Ogata Cell surface receptor function of amyloid precursor protein that activates Ser/Thr kinases Gerontology 42 1996 2 11
130. T. Nakamura, R. Sanokawa, Y. Sasaki, D. Ayusawa, M. Oishi, and N. Mori N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway Oncogene 13 1996 1111 1121
131. T. Nakamura, S. Muraoka, R. Sanokawa, and N. Mori N-Shc and Sck, two neuronally expressed Shc adapter homologs: their differential regional expression in the brain and roles in neurotrophin and Src signaling J. Biol. Chem. 273 1998 6960 6967
132. T. Nakamura, M. Komiya, N. Gotoh, S. Koizumi, M. Shibuya, and N. Mori Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules Oncogene 21 2002 22 31
133. S. Noselli JNK signaling and morphogenesis in Drosophila Trends Genet. 14 1998 33 38
134. S. Noselli, and F. Agnes Roles of the JNK signaling pathway in Drosophila morphogenesis Curr. Opin. Genet. Dev. 9 1999 466 472
135. T. Obata, G.E. Brown, and M.B. Yaffe MAP kinase pathways activated by stress: the p38 MAPK pathway Crit. Care Med. 28 2000 N67 N77
136. T. Okamoto, S. Takeda, Y. Murayama, E. Ogata, and I. Nishimoto Ligand-dependent G protein coupling function of amyloid transmembrane precursor J. Biol. Chem. 270 1995 4205 4208
137. H. Okazawa, and S. Estus The JNK/c-Jun cascade and Alzheimer's disease Am. J. Alzheimers Dis. Other Demen. 17 2002 79 88
138. K. Ono, and J. Han The p38 signal transduction pathway: activation and function Cell Signal 12 2000 1 13
139. C. Otth, A. Mendoza-Naranjo, L. Mujica, A. Zambrano, I.I. Concha, and R.B. Maccioni Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease NeuroReport 14 2003 2403 2409
140. D. Paris, J. Humphrey, A. Quadros, N. Patel, R. Crescentini, F. Crawford, and M. Mullan Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation Neurol. Res. 25 2003 642 651
141. J.T. Parsons, and S.J. Parsons Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways Curr. Opin. Cell Biol. 9 1997 187 192
142. T. Pawson Tyrosine kinase signaling pathways Princess Takamatsu. Symp. 24 1994 303 322
143. G. Pearson, R. Bumeister, D.O. Henry, M.H. Cobb, and M.A. White Uncoupling Raf-1 from MEK1/2 impairs only a subset of cellular responses to Raf activation J. Biol. Chem. 275 2000 37303 37306
144. G. Pearson, F. Robinson, Beers, T. Gibson, B.E. Xu, M. Karandikar, K. Berman, and M.H. Cobb Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr. Rev. 22 2001 153 183
145. A.L. Peel PKR activation in neurodegenerative disease J. Neuropathol. Exp. Neurol. 63 2004 97 105
146. J.J. Pei, C.X. Gong, W.L. An, B. Winblad, R.F. Cowburn, I. Grundke-Iqbal, and K. Iqbal Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease Am. J. Pathol. 163 2003 845 858
147. C. Peyssonnaux, and A. Eychene The Raf/MEK/ERK pathway: new concepts of activation Biol. Cell 93 2001 53 62
148. K.L. Pierce, L.M. Luttrell, and R.J. Lefkowitz New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades Oncogene 20 2001 1532 1539
149. S. Plyte, M.B. Majolini, S. Pacini, F. Scarpini, C. Bianchini, L. Lanfrancone, P. Pelicci, and C.T. Baldari Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts Oncogene 19 2000 1529 1537
150. J.P. Pursiheimo, A. Kieksi, M. Jalkanen, and M. Salmivirta Protein kinase A balances the growth factor-induced Ras/ERK signaling FEBS Lett. 521 2002 157 164
151. R.A. Quintanilla, D.I. Orellana, C. Gonzalez-Billault, and R.B. Maccioni Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway Exp. Cell Res. 295 2004 245 257
152. R. Raghunandan, and V.M. Ingram Hyper-phosphorylation of the cytoskeletal protein Tau by the MAP-kinase PK40erk2: regulation by prior phosphorylation with cAMP-dependent protein kinase A Biochem. Biophys. Res. Commun. 215 1995 1056 1066
153. M. Rapoport, and A. Ferreira PD-98059 prevents neurite degeneration induced by fibrillar β-amyloid in mature hippocampal neurons J. Neurochem. 74 2000 125 133
154. K.S. Ravichandran Signaling via Shc family adapter proteins Oncogene 20 2001 6322 6330
155. L.B. Ray, and T.W. Sturgill Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro Proc. Natl. Acad. Sci. U.S.A. 84 1987 1502 1506
156. C.H. Reynolds, J.C. Betts, W.P. Blackstock, A.R. Nebreda, and B.H. Anderton Phosphorylation sites on Tau identified by nano-electrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and p38, and glycogen synthase kinase-3β J. Neurochem. 74 2000 1587 1595
157. M. Rincon MAP-kinase signaling pathways in T cells Curr. Opin. Immunol. 13 2001 339 345
158. M. Rincon, R.A. Flavell, and R.A. Davis The JNK and p38 MAP kinase signaling pathways in T cell-mediated immune responses Free Radic. Biol. Med. 28 2000 1328 1337
159. ERK converts Tau into a PHF-like form as found in Alzheimer's disease Biochem. Biophys. Res. Commun. 193 1993 639 647
160. H.M. Roder, F.J. Hoffman, and W. Schroder Phosphatase resistance of ERK2 brain kinase PK40erk2 J. Neurochem. 64 1995 2203 2212
161. H.M. Roder, R.P. Fracasso, F.J. Hoffman, J.A. Witowsky, G. Davis, and C.B. Pellegrino Phosphorylation-dependent monoclonal Tau antibodies do not reliably report phosphorylation by extracellular signal-regulated kinase 2 at specific sites J. Biol. Chem. 272 1997 4509 4515
162. E. Runden, P.O. Seglen, F.M. Haug, O.P. Ottersen, T. Wieloch, M. Shamloo, and J.H. Laake Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism J. Neurosci. 18 1998 7296 7305
163. N. Sato, K. Kamino, K. Tateishi, T. Satoh, Y. Nishiwaki, A. Yoshiiwa, T. Miki, and T. Ogihara Elevated amyloid β protein(1-40) level induces CREB phosphorylation at serine-133 via p44/42 MAP kinase (ERK1/2)-dependent pathway in rat pheochromocytoma PC-12 cells Biochem. Biophys. Res. Commun. 232 1997 637 642
164. M.J. Savage, Y.G. Lin, J.R. Ciallella, D.G. Flood, and R.W. Scott Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition J. Neurosci. 22 2002 3376 3385
165. J.S. Sebolt-Leopold Development of anticancer drugs targeting the MAP kinase pathway Oncogene 19 2000 6594 6599
166. D.J. Selkoe Amyloid protein and Alzheimer's disease Sci. Am. 265 1991 68 78
167. T.K. Schlesinger, G.R. Fanger, T. Yujiri, and G.L. Johnson The TAO of MEKK Front. Biosci. 3 1998 D1181 D1186
168. A. Schneider, J. Biernat, M. von Bergen, E. Mandelkow, and E.M. Mandelkow Phosphorylation that detaches Tau protein from microtubules (Ser-262, Ser-214) also protects it against aggregation into Alzheimer paired helical filaments Biochemistry 38 1999 3549 3558
169. A. Shanavas, and S.C. Papasozomenos Tau kinases in the rat heat shock model: possible implications for Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 97 2000 14139 14144
170. J.G. Sheng, R.A. Jones, X.Q. Zhou, J.M. McGinness, L.J. Van Eldik, R.E. Mrak, and W.S. Griffin Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for Tau protein phosphorylation Neurochem. Int. 39 2001 341 348
171. J.E. Shin, J.Y. Koh, and I. Mook-Jung Presenilin 1 mediates protein kinase C dependent α-secretase derived amyloid precursor protein secretion and mitogen-activated protein kinase activation in presenilin 1 transfected human embryonic kidney 293 cell Neurosci. Lett. 269 1999 99 102
172. H.A. Smits, N.M. de Vos, J.W. Wat, T. van der Bruggen, J. Verhoef, and H.S. Nottet Intracellular pathways involved in TNF-α and superoxide anion release by Aβ(1-42)-stimulated primary human macrophages J. Neuroimmunol. 115 2001 144 151
173. D.C. Solano, M. Sironi, C. Bonfini, S.B. Solerte, S. Govoni, and M. Racchi Insulin regulates soluble amyloid precursor protein release via phosphatidylinositol 3 kinase-dependent pathway FASEB J. 14 2000 1015 1022
174. E. Sontag Protein phosphatase 2A: the Trojan Horse of cellular signaling Cell Signal 13 2001 7 16
175. P.H. St. George-Hyslop Piecing together Alzheimer's Sci. Am. 283 2000 76 83
176. C.L. Standen, J. Brownlees, A.J. Grierson, S. Kesavapany, K.F. Lau, D.M. McLoughlin, and C.C. Miller Phosphorylation of Thr-668 in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3) J. Neurochem. 76 2001 316 320
177. T.D. Stein, and J.A. Johnson Genetic programming by the proteolytic fragments of the amyloid precursor protein: somewhere between confusion and clarity Rev. Neurosci. 14 2003 317 341
178. P.H. Sugden, and A. Clerk Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors Cell Signal 9 1997 337 351
179. A. Sun, M. Liu, X.V. Nguyen, and G. Bing P38 MAP kinase is activated at early stages in Alzheimer's disease brain Exp. Neurol. 183 2003 394 405
180. A. Takeda, G. Perry, N.G. Abraham, B.E. Dwyer, R.K. Kutty, J.T. Laitinen, R.B. Petersen, and M.A. Smith Over-expression of heme oxygenase in neuronal cells, the possible interaction with Tau J. Biol. Chem. 275 2000 5395 5399
181. J. Tan, T. Town, T. Mori, Y. Wu, M. Saxe, F. Crawford, and M. Mullan CD45 opposes β-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase J. Neurosci. 20 2000 7587 7594
182. T. Tanaka, J. Zhong, K. Iqbal, E. Trenkner, and I. Grundke-Iqbal The regulation of phosphorylation of Tau in SY5Y neuroblastoma cells: the role of protein phosphatases FEBS Lett. 426 1998 248 254
183. H. Taru, K. Iijima, M. Hase, Y. Kirino, Y. Yagi, and T. Suzuki Interaction of Alzheimer's β-amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade J. Biol. Chem. 277 2002 20070 20078
184. X. Tian, and L.A. Feig Basis for signaling specificity difference between Sos and Ras-GRF guanine nucleotide exchange factors J. Biol. Chem. 276 2001 47248 47256
185. L.A. Tibbles, and J.R. Woodgett The stress-activated protein kinase pathways Cell. Mol. Life Sci. 55 1999 1230 1254
186. Y. Tomidokoro, K. Ishiguro, Y. Harigaya, E. Matsubara, M. Ikeda, J.M. Park, K. Yasutake, T. Kawarabayashi, K. Okamoto, and M. Shoji Aβ amyloidosis induces the initial stage of Tau accumulation in APP(Sw) mice Neurosci. Lett. 299 2001 169 172
187. J.Q. Trojanowski, M. Mawal-Dewan, M.L. Schmidt, J. Martin, and V.M. Lee Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites Brain Res. 618 1993 333 337
188. C.M. Troy, S.A. Rabacchi, Z. Xu, A.C. Maroney, T.J. Connors, M.L. Shelanski, and L.A. Greene β-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation J. Neurochem. 77 2001 157 164
189. L.H. Wang, C.G. Besirli, and E.M. Johnson Jr. Mixed-lineage kinases: a target for the prevention of neurodegeneration Annu. Rev. Pharmacol. Toxicol. 44 2004 451 474
190. C.R. Weinstein-Oppenheimer, W.L. Blalock, L.S. Steelman, F. Chang, and J.A. McCubrey The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors Pharmacol. Ther. 88 2000 229 279
191. C.R. Weston, and R.J. Davis The JNK signal transduction pathway Curr. Opin. Genet. Dev. 12 2002 14 21
192. R. Williamson, T. Scales, B.R. Clark, G. Gibb, C.H. Reynolds, S. Kellie, I.N. Bird, I.M. Varndell, P.W. Sheppard, I. Everall, and B.H. Anderton Rapid tyrosine phosphorylation of neuronal proteins including Tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases J. Neurosci. 22 2002 10 20
193. R.J. Wurtman Alzheimer's disease Sci. Am. 252 1985 62 74
194. M.Q. Xia, B.J. Bacskai, R.B. Knowles, S.X. Qin, and B.T. Hyman Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease J. Neuroimmunol. 108 2000 227 235
195. M. Xia, and B.T. Hyman GROα/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for Tau hyper-phosphorylation: A role in Alzheimer's disease? J. Neuroimmunol. 122 2002 55 64
196. H. Yamaguchi, K. Ishiguro, T. Uchida, A. Takashima, C.A. Lemere, and K. Imahori Preferential labeling of Alzheimer neurofibrillary tangles with antisera for Tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II Acta. Neuropathol. (Berl.) 92 1996 232 241
197. Z. Yao, K. Diener, X.S. Wang, M. Zukowski, G. Matsumoto, G. Zhou, R. Mo, T. Sasaki, H. Nishina, C.C. Hui, T.H. Tan, J.P. Woodgett, and J.M. Penninger Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase J. Biol. Chem. 272 1997 32378 32383
198. L. Zhang, and R.S. Jope Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells Neurobiol. Aging 20 1999 271 278
199. W. Zhang, T. Chen, T. Wan, L. He, N. Li, Z. Yuan, and X. Cao Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways Biochem. Biophys. Res. Commun. 274 2000 872 879
200. W.Q. Zhao, C. Feng, and D.L. Alkon Impairment of phosphatase 2A contributes to the prolonged MAP kinase phosphorylation in Alzheimer's disease fibroblasts Neurobiol. Dis. 14 2003 458 469
201. X. Zhu, C.A. Rottkamp, H. Boux, A. Takeda, G. Perry, and M.A. Smith Activation of p38 kinase links Tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease J. Neuropathol. Exp. Neurol. 59 2000 880 888
202. X. Zhu, R.J. Castellani, A. Takeda, A. Nunomura, C.S. Atwood, G. Perry, and M.A. Smith Differential activation of neuronal ERK JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis Mech. Ageing Dev. 123 2001 39 46
203. X. Zhu, C.A. Rottkamp, A. Hartzler, Z. Sun, A. Takeda, H. Boux, S. Shimohama, G. Perry, and M.A. Smith Activation of MKK6, an upstream activator of p38, in Alzheimer's disease J. Neurochem. 79 2001 311 318
204. X. Zhu, H.G. Lee, A.K. Raina, G. Perry, and M.A. Smith The role of mitogen-activated protein kinase pathways in Alzheimer's disease Neurosignals 11 2002 270 281